JOURNAL OF CELLULAR AND MOLECULAR MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2115051, encodeId=44b02115051a7, content=今年已经不在预警名单里了，为啥NCBI上还是有预警标志呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c27c5648137, createdName=ms4000001596345783, createdTime=Fri Feb 17 10:05:01 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070717, encodeId=3a7610e07173e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：分子生物学;分子医学 经验分享：under review了快四个月了，我的天，想撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d545592040, createdName=吉川李春代, createdTime=Tue Nov 16 11:48:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602116, encodeId=c19f6021168f, content=请问accept,complete final file updates之后还有哪些步骤呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200710/10bd1d998fe04dde83a0c3bd61e524c7/007df3473bde4e64badd227207aff0c3.jpg, createdBy=c0b12110388, createdName=@gns, createdTime=Fri Jun 12 13:12:34 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182899, encodeId=d8cc1182899ff, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：亲，大家有知道文章接收后大约多久出清样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f05571210, createdName=ms8000000012178915, createdTime=Mon Jan 10 17:42:58 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082997, encodeId=9074108299ea6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞分化;血液病 经验分享：速度还是可以的，9月投稿，34天一审结束，大修两个月，我补完实验花费一个月时间；二审大概18天，要了部分图片的原始数据，9天后接受。二个审稿人，问题不是太多，但是很有建设性意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3d5645619, createdName=ms3000000126627097, createdTime=Wed Dec 22 10:31:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081071, encodeId=991310810e1de, content=请问，这个的版面费是多少呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLgKgjk4tGhPfZWl1xQEB0C9XAnhZ01IrysHHgOB5yOUkQ593dMpPEpT7ickmpbeHw6F5eqiaa0zqYA/132, createdBy=932d5290144, createdName=sulihuang, createdTime=Fri Dec 17 10:29:22 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578404, encodeId=ab455e8404b4, content=杂志修改过程很慢，接收后到查到WOS收录就快了，毕业没问题，放心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/19bb2276d728d0870371826cbbeecedc.jpg, createdBy=9c122013525, createdName=受伤的鱼儿, createdTime=Thu Oct 24 00:00:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811200, encodeId=d40881120068, content=请问这个期刊最后会需要原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8482359987, createdName=13801380, createdTime=Wed Aug 19 21:32:51 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2024-02-17 ms6000001781103027 来自江西省

under review是内审还是外审？

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2115051, encodeId=44b02115051a7, content=今年已经不在预警名单里了，为啥NCBI上还是有预警标志呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c27c5648137, createdName=ms4000001596345783, createdTime=Fri Feb 17 10:05:01 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070717, encodeId=3a7610e07173e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：分子生物学;分子医学 经验分享：under review了快四个月了，我的天，想撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d545592040, createdName=吉川李春代, createdTime=Tue Nov 16 11:48:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602116, encodeId=c19f6021168f, content=请问accept,complete final file updates之后还有哪些步骤呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200710/10bd1d998fe04dde83a0c3bd61e524c7/007df3473bde4e64badd227207aff0c3.jpg, createdBy=c0b12110388, createdName=@gns, createdTime=Fri Jun 12 13:12:34 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182899, encodeId=d8cc1182899ff, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：亲，大家有知道文章接收后大约多久出清样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f05571210, createdName=ms8000000012178915, createdTime=Mon Jan 10 17:42:58 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082997, encodeId=9074108299ea6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞分化;血液病 经验分享：速度还是可以的，9月投稿，34天一审结束，大修两个月，我补完实验花费一个月时间；二审大概18天，要了部分图片的原始数据，9天后接受。二个审稿人，问题不是太多，但是很有建设性意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3d5645619, createdName=ms3000000126627097, createdTime=Wed Dec 22 10:31:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081071, encodeId=991310810e1de, content=请问，这个的版面费是多少呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLgKgjk4tGhPfZWl1xQEB0C9XAnhZ01IrysHHgOB5yOUkQ593dMpPEpT7ickmpbeHw6F5eqiaa0zqYA/132, createdBy=932d5290144, createdName=sulihuang, createdTime=Fri Dec 17 10:29:22 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578404, encodeId=ab455e8404b4, content=杂志修改过程很慢，接收后到查到WOS收录就快了，毕业没问题，放心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/19bb2276d728d0870371826cbbeecedc.jpg, createdBy=9c122013525, createdName=受伤的鱼儿, createdTime=Thu Oct 24 00:00:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811200, encodeId=d40881120068, content=请问这个期刊最后会需要原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8482359987, createdName=13801380, createdTime=Wed Aug 19 21:32:51 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2023-09-12 ms1000000858912769 来自华盛顿

生信加实验会收吗

25 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2115051, encodeId=44b02115051a7, content=今年已经不在预警名单里了，为啥NCBI上还是有预警标志呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c27c5648137, createdName=ms4000001596345783, createdTime=Fri Feb 17 10:05:01 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070717, encodeId=3a7610e07173e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：分子生物学;分子医学 经验分享：under review了快四个月了，我的天，想撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d545592040, createdName=吉川李春代, createdTime=Tue Nov 16 11:48:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602116, encodeId=c19f6021168f, content=请问accept,complete final file updates之后还有哪些步骤呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200710/10bd1d998fe04dde83a0c3bd61e524c7/007df3473bde4e64badd227207aff0c3.jpg, createdBy=c0b12110388, createdName=@gns, createdTime=Fri Jun 12 13:12:34 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182899, encodeId=d8cc1182899ff, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：亲，大家有知道文章接收后大约多久出清样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f05571210, createdName=ms8000000012178915, createdTime=Mon Jan 10 17:42:58 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082997, encodeId=9074108299ea6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞分化;血液病 经验分享：速度还是可以的，9月投稿，34天一审结束，大修两个月，我补完实验花费一个月时间；二审大概18天，要了部分图片的原始数据，9天后接受。二个审稿人，问题不是太多，但是很有建设性意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3d5645619, createdName=ms3000000126627097, createdTime=Wed Dec 22 10:31:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081071, encodeId=991310810e1de, content=请问，这个的版面费是多少呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLgKgjk4tGhPfZWl1xQEB0C9XAnhZ01IrysHHgOB5yOUkQ593dMpPEpT7ickmpbeHw6F5eqiaa0zqYA/132, createdBy=932d5290144, createdName=sulihuang, createdTime=Fri Dec 17 10:29:22 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578404, encodeId=ab455e8404b4, content=杂志修改过程很慢，接收后到查到WOS收录就快了，毕业没问题，放心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/19bb2276d728d0870371826cbbeecedc.jpg, createdBy=9c122013525, createdName=受伤的鱼儿, createdTime=Thu Oct 24 00:00:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811200, encodeId=d40881120068, content=请问这个期刊最后会需要原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8482359987, createdName=13801380, createdTime=Wed Aug 19 21:32:51 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2023-02-17 ms4000001596345783

今年已经不在预警名单里了，为啥NCBI上还是有预警标志呢？

47 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2115051, encodeId=44b02115051a7, content=今年已经不在预警名单里了，为啥NCBI上还是有预警标志呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c27c5648137, createdName=ms4000001596345783, createdTime=Fri Feb 17 10:05:01 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070717, encodeId=3a7610e07173e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：分子生物学;分子医学 经验分享：under review了快四个月了，我的天，想撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d545592040, createdName=吉川李春代, createdTime=Tue Nov 16 11:48:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602116, encodeId=c19f6021168f, content=请问accept,complete final file updates之后还有哪些步骤呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200710/10bd1d998fe04dde83a0c3bd61e524c7/007df3473bde4e64badd227207aff0c3.jpg, createdBy=c0b12110388, createdName=@gns, createdTime=Fri Jun 12 13:12:34 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182899, encodeId=d8cc1182899ff, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：亲，大家有知道文章接收后大约多久出清样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f05571210, createdName=ms8000000012178915, createdTime=Mon Jan 10 17:42:58 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082997, encodeId=9074108299ea6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞分化;血液病 经验分享：速度还是可以的，9月投稿，34天一审结束，大修两个月，我补完实验花费一个月时间；二审大概18天，要了部分图片的原始数据，9天后接受。二个审稿人，问题不是太多，但是很有建设性意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3d5645619, createdName=ms3000000126627097, createdTime=Wed Dec 22 10:31:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081071, encodeId=991310810e1de, content=请问，这个的版面费是多少呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLgKgjk4tGhPfZWl1xQEB0C9XAnhZ01IrysHHgOB5yOUkQ593dMpPEpT7ickmpbeHw6F5eqiaa0zqYA/132, createdBy=932d5290144, createdName=sulihuang, createdTime=Fri Dec 17 10:29:22 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578404, encodeId=ab455e8404b4, content=杂志修改过程很慢，接收后到查到WOS收录就快了，毕业没问题，放心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/19bb2276d728d0870371826cbbeecedc.jpg, createdBy=9c122013525, createdName=受伤的鱼儿, createdTime=Thu Oct 24 00:00:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811200, encodeId=d40881120068, content=请问这个期刊最后会需要原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8482359987, createdName=13801380, createdTime=Wed Aug 19 21:32:51 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2021-11-16 吉川李春代

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：分子生物学;分子医学
经验分享：under review了快四个月了，我的天，想撤稿

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2115051, encodeId=44b02115051a7, content=今年已经不在预警名单里了，为啥NCBI上还是有预警标志呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c27c5648137, createdName=ms4000001596345783, createdTime=Fri Feb 17 10:05:01 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070717, encodeId=3a7610e07173e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：分子生物学;分子医学 经验分享：under review了快四个月了，我的天，想撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d545592040, createdName=吉川李春代, createdTime=Tue Nov 16 11:48:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602116, encodeId=c19f6021168f, content=请问accept,complete final file updates之后还有哪些步骤呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200710/10bd1d998fe04dde83a0c3bd61e524c7/007df3473bde4e64badd227207aff0c3.jpg, createdBy=c0b12110388, createdName=@gns, createdTime=Fri Jun 12 13:12:34 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182899, encodeId=d8cc1182899ff, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：亲，大家有知道文章接收后大约多久出清样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f05571210, createdName=ms8000000012178915, createdTime=Mon Jan 10 17:42:58 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082997, encodeId=9074108299ea6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞分化;血液病 经验分享：速度还是可以的，9月投稿，34天一审结束，大修两个月，我补完实验花费一个月时间；二审大概18天，要了部分图片的原始数据，9天后接受。二个审稿人，问题不是太多，但是很有建设性意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3d5645619, createdName=ms3000000126627097, createdTime=Wed Dec 22 10:31:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081071, encodeId=991310810e1de, content=请问，这个的版面费是多少呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLgKgjk4tGhPfZWl1xQEB0C9XAnhZ01IrysHHgOB5yOUkQ593dMpPEpT7ickmpbeHw6F5eqiaa0zqYA/132, createdBy=932d5290144, createdName=sulihuang, createdTime=Fri Dec 17 10:29:22 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578404, encodeId=ab455e8404b4, content=杂志修改过程很慢，接收后到查到WOS收录就快了，毕业没问题，放心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/19bb2276d728d0870371826cbbeecedc.jpg, createdBy=9c122013525, createdName=受伤的鱼儿, createdTime=Thu Oct 24 00:00:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811200, encodeId=d40881120068, content=请问这个期刊最后会需要原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8482359987, createdName=13801380, createdTime=Wed Aug 19 21:32:51 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2020-06-12 @gns

请问accept,complete final file updates之后还有哪些步骤呢

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2115051, encodeId=44b02115051a7, content=今年已经不在预警名单里了，为啥NCBI上还是有预警标志呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c27c5648137, createdName=ms4000001596345783, createdTime=Fri Feb 17 10:05:01 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070717, encodeId=3a7610e07173e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：分子生物学;分子医学 经验分享：under review了快四个月了，我的天，想撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d545592040, createdName=吉川李春代, createdTime=Tue Nov 16 11:48:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602116, encodeId=c19f6021168f, content=请问accept,complete final file updates之后还有哪些步骤呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200710/10bd1d998fe04dde83a0c3bd61e524c7/007df3473bde4e64badd227207aff0c3.jpg, createdBy=c0b12110388, createdName=@gns, createdTime=Fri Jun 12 13:12:34 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182899, encodeId=d8cc1182899ff, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：亲，大家有知道文章接收后大约多久出清样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f05571210, createdName=ms8000000012178915, createdTime=Mon Jan 10 17:42:58 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082997, encodeId=9074108299ea6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞分化;血液病 经验分享：速度还是可以的，9月投稿，34天一审结束，大修两个月，我补完实验花费一个月时间；二审大概18天，要了部分图片的原始数据，9天后接受。二个审稿人，问题不是太多，但是很有建设性意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3d5645619, createdName=ms3000000126627097, createdTime=Wed Dec 22 10:31:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081071, encodeId=991310810e1de, content=请问，这个的版面费是多少呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLgKgjk4tGhPfZWl1xQEB0C9XAnhZ01IrysHHgOB5yOUkQ593dMpPEpT7ickmpbeHw6F5eqiaa0zqYA/132, createdBy=932d5290144, createdName=sulihuang, createdTime=Fri Dec 17 10:29:22 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578404, encodeId=ab455e8404b4, content=杂志修改过程很慢，接收后到查到WOS收录就快了，毕业没问题，放心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/19bb2276d728d0870371826cbbeecedc.jpg, createdBy=9c122013525, createdName=受伤的鱼儿, createdTime=Thu Oct 24 00:00:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811200, encodeId=d40881120068, content=请问这个期刊最后会需要原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8482359987, createdName=13801380, createdTime=Wed Aug 19 21:32:51 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2022-01-10 ms8000000012178915

审稿速度:2.0
偏重的研究方向：心血管
经验分享：亲，大家有知道文章接收后大约多久出清样

39 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2115051, encodeId=44b02115051a7, content=今年已经不在预警名单里了，为啥NCBI上还是有预警标志呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c27c5648137, createdName=ms4000001596345783, createdTime=Fri Feb 17 10:05:01 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070717, encodeId=3a7610e07173e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：分子生物学;分子医学 经验分享：under review了快四个月了，我的天，想撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d545592040, createdName=吉川李春代, createdTime=Tue Nov 16 11:48:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602116, encodeId=c19f6021168f, content=请问accept,complete final file updates之后还有哪些步骤呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200710/10bd1d998fe04dde83a0c3bd61e524c7/007df3473bde4e64badd227207aff0c3.jpg, createdBy=c0b12110388, createdName=@gns, createdTime=Fri Jun 12 13:12:34 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182899, encodeId=d8cc1182899ff, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：亲，大家有知道文章接收后大约多久出清样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f05571210, createdName=ms8000000012178915, createdTime=Mon Jan 10 17:42:58 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082997, encodeId=9074108299ea6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞分化;血液病 经验分享：速度还是可以的，9月投稿，34天一审结束，大修两个月，我补完实验花费一个月时间；二审大概18天，要了部分图片的原始数据，9天后接受。二个审稿人，问题不是太多，但是很有建设性意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3d5645619, createdName=ms3000000126627097, createdTime=Wed Dec 22 10:31:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081071, encodeId=991310810e1de, content=请问，这个的版面费是多少呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLgKgjk4tGhPfZWl1xQEB0C9XAnhZ01IrysHHgOB5yOUkQ593dMpPEpT7ickmpbeHw6F5eqiaa0zqYA/132, createdBy=932d5290144, createdName=sulihuang, createdTime=Fri Dec 17 10:29:22 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578404, encodeId=ab455e8404b4, content=杂志修改过程很慢，接收后到查到WOS收录就快了，毕业没问题，放心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/19bb2276d728d0870371826cbbeecedc.jpg, createdBy=9c122013525, createdName=受伤的鱼儿, createdTime=Thu Oct 24 00:00:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811200, encodeId=d40881120068, content=请问这个期刊最后会需要原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8482359987, createdName=13801380, createdTime=Wed Aug 19 21:32:51 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2021-12-22 ms3000000126627097

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：细胞分化;血液病
经验分享：速度还是可以的，9月投稿，34天一审结束，大修两个月，我补完实验花费一个月时间；二审大概18天，要了部分图片的原始数据，9天后接受。二个审稿人，问题不是太多，但是很有建设性意见。

33 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2115051, encodeId=44b02115051a7, content=今年已经不在预警名单里了，为啥NCBI上还是有预警标志呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c27c5648137, createdName=ms4000001596345783, createdTime=Fri Feb 17 10:05:01 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070717, encodeId=3a7610e07173e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：分子生物学;分子医学 经验分享：under review了快四个月了，我的天，想撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d545592040, createdName=吉川李春代, createdTime=Tue Nov 16 11:48:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602116, encodeId=c19f6021168f, content=请问accept,complete final file updates之后还有哪些步骤呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200710/10bd1d998fe04dde83a0c3bd61e524c7/007df3473bde4e64badd227207aff0c3.jpg, createdBy=c0b12110388, createdName=@gns, createdTime=Fri Jun 12 13:12:34 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182899, encodeId=d8cc1182899ff, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：亲，大家有知道文章接收后大约多久出清样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f05571210, createdName=ms8000000012178915, createdTime=Mon Jan 10 17:42:58 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082997, encodeId=9074108299ea6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞分化;血液病 经验分享：速度还是可以的，9月投稿，34天一审结束，大修两个月，我补完实验花费一个月时间；二审大概18天，要了部分图片的原始数据，9天后接受。二个审稿人，问题不是太多，但是很有建设性意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3d5645619, createdName=ms3000000126627097, createdTime=Wed Dec 22 10:31:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081071, encodeId=991310810e1de, content=请问，这个的版面费是多少呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLgKgjk4tGhPfZWl1xQEB0C9XAnhZ01IrysHHgOB5yOUkQ593dMpPEpT7ickmpbeHw6F5eqiaa0zqYA/132, createdBy=932d5290144, createdName=sulihuang, createdTime=Fri Dec 17 10:29:22 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578404, encodeId=ab455e8404b4, content=杂志修改过程很慢，接收后到查到WOS收录就快了，毕业没问题，放心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/19bb2276d728d0870371826cbbeecedc.jpg, createdBy=9c122013525, createdName=受伤的鱼儿, createdTime=Thu Oct 24 00:00:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811200, encodeId=d40881120068, content=请问这个期刊最后会需要原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8482359987, createdName=13801380, createdTime=Wed Aug 19 21:32:51 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2021-12-17 sulihuang

请问，这个的版面费是多少呀？

34 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2115051, encodeId=44b02115051a7, content=今年已经不在预警名单里了，为啥NCBI上还是有预警标志呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c27c5648137, createdName=ms4000001596345783, createdTime=Fri Feb 17 10:05:01 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070717, encodeId=3a7610e07173e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：分子生物学;分子医学 经验分享：under review了快四个月了，我的天，想撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d545592040, createdName=吉川李春代, createdTime=Tue Nov 16 11:48:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602116, encodeId=c19f6021168f, content=请问accept,complete final file updates之后还有哪些步骤呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200710/10bd1d998fe04dde83a0c3bd61e524c7/007df3473bde4e64badd227207aff0c3.jpg, createdBy=c0b12110388, createdName=@gns, createdTime=Fri Jun 12 13:12:34 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182899, encodeId=d8cc1182899ff, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：亲，大家有知道文章接收后大约多久出清样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f05571210, createdName=ms8000000012178915, createdTime=Mon Jan 10 17:42:58 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082997, encodeId=9074108299ea6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞分化;血液病 经验分享：速度还是可以的，9月投稿，34天一审结束，大修两个月，我补完实验花费一个月时间；二审大概18天，要了部分图片的原始数据，9天后接受。二个审稿人，问题不是太多，但是很有建设性意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3d5645619, createdName=ms3000000126627097, createdTime=Wed Dec 22 10:31:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081071, encodeId=991310810e1de, content=请问，这个的版面费是多少呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLgKgjk4tGhPfZWl1xQEB0C9XAnhZ01IrysHHgOB5yOUkQ593dMpPEpT7ickmpbeHw6F5eqiaa0zqYA/132, createdBy=932d5290144, createdName=sulihuang, createdTime=Fri Dec 17 10:29:22 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578404, encodeId=ab455e8404b4, content=杂志修改过程很慢，接收后到查到WOS收录就快了，毕业没问题，放心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/19bb2276d728d0870371826cbbeecedc.jpg, createdBy=9c122013525, createdName=受伤的鱼儿, createdTime=Thu Oct 24 00:00:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811200, encodeId=d40881120068, content=请问这个期刊最后会需要原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8482359987, createdName=13801380, createdTime=Wed Aug 19 21:32:51 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2019-10-24 受伤的鱼儿

杂志修改过程很慢，接收后到查到WOS收录就快了，毕业没问题，放心吧

66 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187804, encodeId=ca15218e804af, content=under review是内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4a28492476, createdName=ms6000001781103027, createdTime=Sat Feb 17 18:32:18 CST 2024, time=2024-02-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2157383, encodeId=edfe215e383cd, content=生信加实验会收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Tue Sep 12 18:05:13 CST 2023, time=2023-09-12, status=1, ipAttribution=华盛顿), GetPortalCommentsPageByObjectIdResponse(id=2115051, encodeId=44b02115051a7, content=今年已经不在预警名单里了，为啥NCBI上还是有预警标志呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c27c5648137, createdName=ms4000001596345783, createdTime=Fri Feb 17 10:05:01 CST 2023, time=2023-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070717, encodeId=3a7610e07173e, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：分子生物学;分子医学 经验分享：under review了快四个月了，我的天，想撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d545592040, createdName=吉川李春代, createdTime=Tue Nov 16 11:48:07 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602116, encodeId=c19f6021168f, content=请问accept,complete final file updates之后还有哪些步骤呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200710/10bd1d998fe04dde83a0c3bd61e524c7/007df3473bde4e64badd227207aff0c3.jpg, createdBy=c0b12110388, createdName=@gns, createdTime=Fri Jun 12 13:12:34 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182899, encodeId=d8cc1182899ff, content=审稿速度:2.0 偏重的研究方向：心血管 经验分享：亲，大家有知道文章接收后大约多久出清样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0f05571210, createdName=ms8000000012178915, createdTime=Mon Jan 10 17:42:58 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082997, encodeId=9074108299ea6, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞分化;血液病 经验分享：速度还是可以的，9月投稿，34天一审结束，大修两个月，我补完实验花费一个月时间；二审大概18天，要了部分图片的原始数据，9天后接受。二个审稿人，问题不是太多，但是很有建设性意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a3d5645619, createdName=ms3000000126627097, createdTime=Wed Dec 22 10:31:19 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081071, encodeId=991310810e1de, content=请问，这个的版面费是多少呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLgKgjk4tGhPfZWl1xQEB0C9XAnhZ01IrysHHgOB5yOUkQ593dMpPEpT7ickmpbeHw6F5eqiaa0zqYA/132, createdBy=932d5290144, createdName=sulihuang, createdTime=Fri Dec 17 10:29:22 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578404, encodeId=ab455e8404b4, content=杂志修改过程很慢，接收后到查到WOS收录就快了，毕业没问题，放心吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/19bb2276d728d0870371826cbbeecedc.jpg, createdBy=9c122013525, createdName=受伤的鱼儿, createdTime=Thu Oct 24 00:00:00 CST 2019, time=2019-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811200, encodeId=d40881120068, content=请问这个期刊最后会需要原始数据么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8482359987, createdName=13801380, createdTime=Wed Aug 19 21:32:51 CST 2020, time=2020-08-19, status=1, ipAttribution=)]

2020-08-19 13801380

请问这个期刊最后会需要原始数据么？

62 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务